| Secondary |
| Bronchitis |
11.5% |
| Drug Use For Unknown Indication |
10.4% |
| Product Used For Unknown Indication |
10.0% |
| Gastritis |
8.1% |
| Cough |
5.9% |
| Ill-defined Disorder |
5.6% |
| Bronchopneumonia |
4.8% |
| Nasopharyngitis |
4.8% |
| Pneumonia |
4.8% |
| Bronchitis Acute |
4.4% |
| Bronchitis Chronic |
4.4% |
| Constipation |
4.4% |
| Insomnia |
3.3% |
| Anti-infective Therapy |
3.0% |
| Emphysema |
3.0% |
| Productive Cough |
3.0% |
| Hypertension |
2.6% |
| Anaemia |
2.2% |
| Venous Thrombosis |
2.2% |
| Asthma |
1.5% |
|
| Sepsis |
15.0% |
| Pseudomembranous Colitis |
10.0% |
| Pyrexia |
10.0% |
| Neutropenia |
7.5% |
| Aggression |
5.0% |
| Drug Eruption |
5.0% |
| Drug Ineffective |
5.0% |
| Enanthema |
5.0% |
| Hypertension |
5.0% |
| Interstitial Lung Disease |
5.0% |
| Vomiting |
5.0% |
| Anaphylactic Shock |
2.5% |
| Anaphylactoid Reaction |
2.5% |
| Back Pain |
2.5% |
| Dizziness |
2.5% |
| Feeling Hot |
2.5% |
| Hepatitis |
2.5% |
| Marasmus |
2.5% |
| Mycoplasma Infection |
2.5% |
| Neuropathy Peripheral |
2.5% |
|
| Concomitant |
| Drug Use For Unknown Indication |
19.3% |
| Product Used For Unknown Indication |
18.9% |
| Rheumatoid Arthritis |
11.5% |
| Bronchitis |
6.9% |
| Hypertension |
5.2% |
| Prophylaxis |
4.4% |
| Asthma |
4.3% |
| Diffuse Panbronchiolitis |
3.5% |
| Nasopharyngitis |
3.0% |
| Productive Cough |
2.9% |
| Gastritis |
2.3% |
| Upper Respiratory Tract Inflammation |
2.3% |
| Constipation |
2.2% |
| Insomnia |
2.2% |
| Bronchitis Chronic |
2.1% |
| Hiv Infection |
2.1% |
| Chronic Obstructive Pulmonary Disease |
1.9% |
| Cough |
1.8% |
| Acute Myeloid Leukaemia |
1.6% |
| Diabetes Mellitus |
1.6% |
|
| Pneumonia |
20.0% |
| Vomiting |
8.0% |
| Rhabdomyolysis |
7.4% |
| Rash |
5.7% |
| Hepatic Function Abnormal |
5.1% |
| Pyrexia |
5.1% |
| Death |
4.6% |
| Hypoglycaemia |
4.6% |
| White Blood Cell Count Increased |
4.6% |
| Bronchopneumonia |
3.4% |
| Chromaturia |
3.4% |
| Interstitial Lung Disease |
3.4% |
| Pneumonia Bacterial |
3.4% |
| Sinus Arrhythmia |
3.4% |
| Urinary Retention |
3.4% |
| White Blood Cell Count Decreased |
3.4% |
| Arthralgia |
2.9% |
| Neutropenia |
2.9% |
| Pancytopenia |
2.9% |
| Cyanosis |
2.3% |
|
| Interacting |
| Product Used For Unknown Indication |
100.0% |
|
| Hypocoagulable State |
100.0% |
|
